Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Prophylaxis for Recurrent Pediatric UTI
NCT00789464Phase 2Withdrawn
- Sponsor
- Baylor College of Medicine
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Lactobacillus reuteri DSM 17938 in urinary tract infection (UTI) (2 arms), sponsored by Baylor College of Medicine. Primary endpoint: Rates of bacteriuria at 1 year. Status: withdrawn.
02
Drugs
Lactobacillus reuteri DSM 17938
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT00789464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789464.